Literature DB >> 24327618

Macular microstructures and prognostic factors in myopic subretinal hemorrhages.

Tomoko Asai1, Yasushi Ikuno, Kohji Nishida.   

Abstract

PURPOSE: To investigate microstructural changes and visual prognosis in myopic subretinal hemorrhages (mSH) without choroidal neovascularization (CNV).
METHODS: In this retrospective, observational case series, 13 consecutive eyes with mSH were followed for 6 months. The medical records, fluorescein angiography (FA), and spectral-domain optical coherence tomography (OCT) were reviewed. Fluorescein angiography confirmed the absence of CNV. The baseline and 6-month findings/parameters were investigated, including the maximal hemorrhagic height, intraretinal hyperscattering signal across the retina at 6 months (i.e., intraretinal hyperreflective sign), and integrity of the photoreceptor inner and outer segment (IS/OS) and external limiting membrane (ELM) lines.
RESULTS: The final visual acuity (VA) improved significantly (P = 0.001), and the hemorrhages resolved in 12 (92.3%) eyes by 6 months. The tops of the hemorrhages reached the outer nuclear layer (ONL) in three eyes (23.1%), internal limiting membrane (ILM) in five (38.5%), and between the two layers in five (38.5%). The intraretinal hyperreflective sign in all eyes extended into the ONL in five eyes (38.5%), to the ILM in four (30.8%), and between the two layers in four (30.8%). The location of the hyperreflective signs at 6 months coincided with the ruptured retinal layers at baseline in all eyes. The IS/OS line and the ELM were each intact in six (46.2%) eyes. The final VA was associated significantly with the IS/OS (P < 0.05) and ELM (P < 0.01) integrity.
CONCLUSIONS: The intraretinal hyperreflective sign, presumed to be scarring that enters through the disrupted outer retina, is correlated closely with photoreceptor function.

Entities:  

Keywords:  hemorrhage; myopia; optical coherence tomography

Mesh:

Year:  2014        PMID: 24327618     DOI: 10.1167/iovs.13-12658

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Clinical features of simple hemorrhage and myopic choroidal neovascularization associated with lacquer cracks in pathologic myopia.

Authors:  Peifang Ren; Li Lu; Xuyuan Tang; Hong Lu; Yuan Zhao; Dinghua Lou; Wei Han
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-07-09       Impact factor: 3.117

2.  Is ellipsoid zone integrity essential for visual recovery in myopic neovascularization after anti-VEGF therapy?

Authors:  Paolo Milani; Marco Pellegrini; Amedeo Massacesi; Stefania Moschini; Marco Setaccioli; Davide Soranna; Antonella Zambon; Ferdinando Bottoni; Fulvio Bergamini
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-30       Impact factor: 3.117

3.  Multimodal imaging of linear lesions in the fundus of pathologic myopic eyes with macular lesions.

Authors:  Kuo-Chi Hung; Muh-Shy Chen; Chung-May Yang; Shih-Wen Wang; Tzyy-Chang Ho
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-10-31       Impact factor: 3.117

4.  Prediction of the short-term efficacy of anti-VEGF therapy for neovascular age-related macular degeneration using optical coherence tomography angiography.

Authors:  Huixun Jia; Bing Lu; Zhi Zhao; Yang Yu; Fenghua Wang; Minwen Zhou; Xiaodong Sun
Journal:  Eye Vis (Lond)       Date:  2022-05-01

Review 5.  Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography.

Authors:  Sandeep Saxena; Khushboo Srivastav; Chui M Cheung; Joanne Yw Ng; Timothy Yy Lai
Journal:  Clin Ophthalmol       Date:  2014-12-09

6.  Myopic Simple Hemorrhage Presenting as Radial Hemorrhage in Henle's Fiber Layer.

Authors:  Marco Mazzola; Laura Premoli; Cristian Metrangolo; Jennifer Cattaneo; Elias Premi; Simone Donati; Claudio Azzolini
Journal:  Case Rep Ophthalmol       Date:  2021-05-12

7.  Long-Term Natural Outcomes of Simple Hemorrhage Associated with Lacquer Crack in High Myopia: A Risk Factor for Myopic CNV?

Authors:  Bing Liu; Xiongze Zhang; Lan Mi; Ling Chen; Feng Wen
Journal:  J Ophthalmol       Date:  2018-01-24       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.